---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-22-124193"
form_type: "8-K"
ticker: "CLRB"
cik: "0001279704"
company_name: "Cellectar Biosciences, Inc."
filed_at: "2022-12-02T23:59:59+00:00"
generated_at: "2026-06-21T10:07:49.032089+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Cellectar adopts amended bylaws and indemnification agreements for directors and officers

## Summary
- Bylaws amended to include exclusive forum provision and clarify director removal only for cause with majority vote.
- Special meetings of stockholders and stockholder proposals subject to enhanced procedural mechanics.
- Indemnification agreements with each director and executive officer provide full indemnity to extent permitted by Delaware law.
- Company also updated bylaws to reflect current name, DGCL updates, and emergency procedures under Section 110.
- No financial or operational changes reported; governance-only filing.

## SEC filing metadata
- accession: 0001104659-22-124193
- form_type: 8-K
- ticker: CLRB
- cik: 0001279704
- company_name: Cellectar Biosciences, Inc.
- filed_at: 2022-12-02T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 1.01, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1279704/000110465922124193/0001104659-22-124193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1279704/000110465922124193/tm2231728d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-22-124193
- JSON: https://secwatch.observer/filing/0001104659-22-124193.json
- Plain text: https://secwatch.observer/filing/0001104659-22-124193.txt

## Key facts
- Governance Changes
  Cellectar Biosciences, Inc.: Amended and restated by-laws to reflect name change, enhance stockholder meeting mechanics, add director nomination requirements, clarify board procedures, and make other updates (effective 2022-11-29).
  - Change: bylaw amendment
  - Effective: 2022-11-29
  source text: On November 29, 2022, the board of directors (the “ Board ”) of the Company adopted the Amended and Restated By-Laws of the Company (the “ By-Laws ”), effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1279704/000110465922124193/0001104659-22-124193-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.